The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients
{{output}}
Rituximab (RTX) is increasingly used off-label for the treatment of multiple sclerosis (MS), yet real-world evidence from Middle Eastern populations remains limited. This multicenter, retrospective observational study evaluated the effectiveness and safety of ... ...
